Related Experiment Video
Updated: Jul 15, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Inflammation at birth and the insulin-like growth factor system in very preterm infants
I Hansen-Pupp1, L Hellström-Westas, C M Cilio
1Institution of Clinical Sciences and Department of Pediatrics, Lund University, Lund, Sweden. ingrid.pupp@skane.se
Insights
Fetal inflammation in preterm infants is linked to altered Insulin-like Growth Factor (IGF) system levels. These changes may contribute to brain damage development in neonates.
Area of Science:
- Neonatal research
- Perinatal medicine
- Developmental biology
Background:
- Fetal inflammation increases preterm infant brain damage risk.
- Insulin-like Growth Factor-I (IGF-I) is crucial for brain development and has anti-apoptotic effects.
Purpose of the Study:
- Assess IGF-I and IGF binding protein levels at very preterm birth.
- Evaluate the relationship between fetal inflammation and cerebral damage.
Main Methods:
- Analyzed cord blood and neonatal blood (72h) for IGF-I, IGFBP-3, and IGFBP-1 (phosphorylated forms).
- Correlated IGF levels with cytokines (IL-6, IL-8, TNF-alpha) and ultrasound-detected cerebral damage.
- Studied 74 infants (GA 27.1 weeks), analyzing data by birth weight for gestational age.
Main Results:
- In appropriate for gestational age infants, higher IL-6/IL-8 correlated with lower IGF-I.
- Elevated IL-6, IL-8, and TNF-alpha were associated with higher lpIGFBP-1 and hpIGFBP-1 levels.
- Infants with severe intraventricular hemorrhage (Grade III) showed higher lpIGFBP-1 and hpIGFBP-1 in cord blood.
Conclusions:
- Pro-inflammation at birth is associated with alterations in the IGF system.
- These IGF system changes may play a role in the development of brain damage in preterm infants.
Background:
Foetal inflammation is associated with an increased risk of brain damage in preterm infants whereas IGF-I is essential for cerebral development and exhibits anti-apoptotic properties.
Aim:
To assess levels of IGF-I and IGF binding proteins at very preterm birth and to evaluate their relationship with foetal pro-inflammation and cerebral damage.
Methods:
Levels of IGF-I, IGF binding protein 3 (IGFBP-3), high- (hp) and low-phosphorylated (lp) IGFBP-1 in cord blood and neonatal blood at 72 h after delivery were analysed in relation to levels of cytokines and cerebral damage as detected by ultrasound in 74 inborn infants [mean gestational age (GA) 27.1 weeks]. Evaluation was performed separately according to birth weight for GA.
Results:
In cord blood of infants appropriate for gestational age (AGA) higher levels of IL-6 and IL-8 were associated with lower IGF-I (r =-0.38, p = 0.008 and r =-0.36, p = 0.014). Higher levels of IL-6, IL-8 and TNF-alpha were associated with both higher levels of lpIGFBP-1 (r = 0.54, p < 0.001, r = 0.50, p < 0.001 and r = 0.13, p = 0.012, respectively) and hpIGFBP-1 (r = 0.55, p < 0.001, r = 0.45, p = 0.002 and r = 0.32, p = 0.026, respectively). Infants with intraventricular haemorrhage grade III (n = 5) had higher levels of lp/hpIGFBP-1 in cord blood (p = 0.001 and 0.002, respectively).
Conclusion:
Pro-inflammation at birth is associated with changes in the IGF-system. This may be of importance for development of brain damage in preterm infants.
Related Concept Videos
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type I Diabetes I: Introduction
Type I Diabetes II: Pathophysiology
Diabetes Mellitus: Type 2 and Gestational
Development of the Oral Microbiota
